PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1350237-3	1992	Pramipexole decreased serum prolactin levels in a dose-dependent manner, with a maximum effect after 2 to 4 hours.	Pramipexole	0-11	prolactin	Homo sapiens	28-37	
16675366-14	2006	The dopamine agonists used to treat Parkinson"s disease--bromocriptine, pergolide, pramipexole, ropinerole--usually reverse antipsychotic-induced prolactin increases without compromising psychiatric effectiveness.	Pramipexole	83-94	prolactin	Homo sapiens	146-155	
22153972-2	2012	Pramipexole was generally well-tolerated (82% trial-completion), and yielded greater decreases in PANSS-total scores (drug/placebo=2.1; p=0.04), with similar decreases in PANSS positive and negative scores and 6.7-fold greater reduction of serum prolactin concentrations compared to placebo.	Pramipexole	0-11	prolactin	Homo sapiens	246-255	
17578485-10	2007	Pramipexole reduced prolactin and increased GH concentrations.	Pramipexole	0-11	prolactin	Homo sapiens	20-29	
16401653-8	2006	Pramipexole reduced alertness, caused pupil dilatation, increased heart rate, reduced prolactin and thyroid stimulating hormone, and increased growth hormone level.	Pramipexole	0-11	prolactin	Homo sapiens	86-95